Transgene

Stocks

Market Closed - Euronext Paris Other stock markets 09:25:00 03/07/2026 pm IST			5-day change	1st Jan Change
0.7550 ^EUR	+3.85%		+3.28%	-21.35%

29/06	Transgene SA - Special Call
25/06	Oddo BHF Stays Positive on Transgene

Published on 06/29/2026 at 08:05 pm IST - Modified on 06/30/2026 at 02:22 am IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good morning, and welcome to the Transgene virtual key opinion leader event. At this time, all attendees are in a listen-only mode and a

[

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

29/06	Transgene SA - Special Call
25/06	Oddo BHF Stays Positive on Transgene
25/06	Positive Preclinical Data for a Transgene Vaccine
25/06	Transgene Presents Preclinical Data Demonstrating Robust Protection Against Mpox With Its Novel Scalable Cell Line?Derived MVA Vaccine Candidate TG-MVATM	CI
22/06	Transgene Expands myvac® into Non-Small Cell Lung Cancer with TG4070, an Individualized Neoantigen Therapeutic Vaccine	CI
22/06	Transgene launches a clinical trial evaluating TG4070 with nivolumab
22/06	Transgene Begins Phase 1 Trial of Non-small Cell Lung Cancer Vaccine	MT
22/05	Transgene SA Announces Board Appointments	CI
13/04	Transgene Completes Patient Randomization in Phase 2 Clinical Trial Evaluating TG4050 in Adjuvant Treatment of Head and Neck Cancer	CI
07/04	Transgene stands out following licensing agreement with NEC Bio
03/04	Transgene, NEC Bio Enter Partnership to Develop Cancer Vaccine	MT
03/04	Transgene and NEC Bio Sign License Agreement for TG4050 Development in Head and Neck Cancer	CI
02/04	Transgene & NEC Bio sign license agreement to prepare next steps of development of TG4050 in head & neck cancer	RE
25/03	Danone, Dassault Systèmes, Orange... stocks to watch today in Paris
25/03	Transgene SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI